Thrombolytic therapy for thrombosis of continuous flow ventricular assist devices

Journal of Cardiac Failure

Volumn 20, Issue 2, 2014, Pages 91-97

  Schlendorf, Kelly ^a   Patel, Chetan B ^a   Gehrig, Thomas ^a   Kiefer, Todd L ^a   Felker, G Michael ^a   Hernandez, Adrian F ^a   Blue, Laura J ^a   Milano, Carmelo A ^a   Rogers, Joseph G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Circulatory support; heart failure; thrombosis

Indexed keywords

CIRCULATORY SUPPORT; HEART FAILURE; THROMBOSIS;

ADULT; AGED; FEMALE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84894589687     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2013.12.011     Document Type: Article

References (29)

1. G. Girdhar, and D. Bluestein Biological effects of dynamic shear stress in cardiovascular pathologies and devices Expert Rev Med Devices 5 2008 167 181
2. M.S. Slaughter Hematologic effects of continuous flow left ventricular assist devices J Cardiovasc Transl Res 3 2010 618 624
3. C.M. Bhamidipati, G. Ailawadi, J. Bergin, and J.A. Kern Early thrombus in a heartmate II left ventricular assist device: a potential cause of hemolysis and diagnostic dilemma J Thorac Cardiovasc Surg 140 2010 e7 e8
4. M.A. Romano, J.W. Haft, and J.M. Stulak Hemolysis predicts poor outcome following lvad implant J Heart Lung Transplant 30 2011 S11
5. P. Shah, V.M. Mehta, J.A. Cowger, K.D. Aaronson, and F.D. Pagani Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support J Heart Lung Transplant 2013 Aug 19 [Epub ahead of print]
6. S.E. Burke, N.L. Lubbers, R.A. Nelson, C.D. Wegner, and B.F. Cox Profile of recombinant pro-urokinase given by intraarterial versus intravenous routes of administration in a canine thrombosis model Thromb Haemost 81 1999 301 305
7. R.C. Starling, N. Moazami, S.C. Silvestry, G. Ewald, and J.G. Rogers et al. Unexpected abrupt increase in left ventricular assist device thrombosis N Engl J Med 370 2014 33 40
8. M.S. Slaughter, J.G. Rogers, C.A. Milano, S.D. Russell, J.V. Conte, and D. Feldman et al. Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
9. S. Crow, R. John, A. Boyle, S. Shumway, K. Liao, and M. Colvin-Adams et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices J Thorac Cardiovasc Surg 137 2009 208 215
10. N. Uriel, S.W. Pak, U.P. Jorde, B. Jude, S. Susen, and A. Vincentelli et al. Acquired von willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation J Am Coll Cardiol 56 2010 1207 1213
11. R. John, F. Kamdar, K. Liao, M. Colvin-Adams, L. Miller, and L. Joyce et al. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device J Thorac Cardiovasc Surg 136 2008 18 1323
12. J.P. Slater, E.A. Rose, H.R. Levin, O.H. Frazier, J.K. Roberts, and A.D. Weinberg et al. Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices Ann Thorac Surg 62 1996 1321 1327 discussion 1328
13. A.J. Boyle, S.D. Russell, J.J. Teuteberg, M.S. Slaughter, N. Moazami, and F.D. Pagani et al. Low thromboembolism and pump thrombosis with the Heartmate II left ventricular assist device: analysis of outpatient anticoagulation J Heart Lung Transplant 28 2009 881 887
14. D.J. Goldstein, R. John, C. Salerno, S. Silvestry, and N. Moazami et al. Algorithm for the diagnosis and management of suspected pump thrombus J Heart Lung Transplant 32 2013 667 670
15. T. Spanier, M. Oz, H. Levin, A. Weinberg, K. Stamatis, and D. Stern et al. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices J Thorac Cardiovasc Surg 112 1996 1090 1097
16. J. Linneweber, T.W. Chow, M. Kawamura, J.L. Moake, and Y. Nose In vitro comparison of blood pump induced platelet microaggregates between a centrifugal and roller pump during cardiopulmonary bypass Int J Artif Organs 25 2002 549 555
17. J.M. Stulak, D. Lee, J.W. Haft, M.A. Romano, and J. Cowger et al. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device J Heart Lung Transplant 2013 Sep 7 [Epub ahead of print]
18. I.D. Gregoric, B.A. Bruckner, L. Jacob, B. Kar, W.E. Cohn, and S. la Francesca et al. Clinical experience with sternotomy versus subcostal approach for exchange of the Heartmate XVE to the Heartmate II ventricular assist device Ann Thorac Surg 85 2008 1646 1649
19. N. Moazami, C.A. Milano, R. John, B. Sun, and R.M. Adamson et al. Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality Ann Thorac Surg 95 2013 500 505
20. P.M. Portner, P.G. Jansen, P.E. Oyer, D.R. Wheeldon, and N. Ramasamy Improved outcomes with an implantable left ventricular assist system: a multicenter study Ann Thorac Surg 71 2001 205 209
21. M. Rothenburger, M.J. Wilhelm, D. Hammel, C. Schmidt, T.D. Tjan, and D. Bocker et al. Treatment of thrombus formation associated with the Micromed Debakey VAD using recombinant tissue plasminogen activator Circulation 106 2002 I189 I192
22. H. Hayes, L. Dembo, R. Larbalestier, and G. O'Driscoll Successful treatment of ventricular assist device associated ventricular thrombus with systemic tenecteplase Heart Lung Circ 17 2008 253 255
23. M.S. Kiernan, D.T. Pham, D. DeNofrio, and N.K. Kapur Management of Heartware left ventricular assist device thrombosis using intracavitary thrombolytics J Thorac Cardiovasc Surg 142 2011 712 714
24. J.M. Rawles Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT) J Am Coll Cardiol 30 1997 1181 1186
25. V. Menon, R.A. Harrington, J.S. Hochman, C.P. Cannon, S.D. Goodman, and R.G. Wilcox et al. Thrombolysis and adjunctive therapy in acute myocardial infarction: the seventh ACCP conference on antithrombotic and thrombolytic therapy Chest 126 2004 549S 575S
26. B. Cucciara, S.E. Kasner, D. Tanne, S.R. Levine, and A. Demchuk et al. Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials Stroke 40 2009 3067 3072
27. C. Gumbinger, P. Gruschka, M. Bottinger, K. Heerlein, and R. Barrows et al. Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage Stroke 43 2012 240 242
28. N. Wahlgren, N. Ahmed, N. Eriksson, F. Aichner, and E. Bluhmki et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) Stroke 39 2008 3316 3322
29. M.S. Slaughter, Y. Naka, R. John, A. Boyle, J.V. Conte, and S.D. Russell et al. Post-operative heparin may not be required for transitioning patients with a Heartmate II left ventricular assist system to long-term warfarin therapy J Heart Lung Transplant 29 2010 616 624